Market Place
Sourcing Support
Debiopharm, Genome Agree On First-In-Class Oncology ADC Family
03 Jun 2024 //
BUSINESSWIRE
Genome & Co. posts data from phase 2 microbiome cancer trial
24 Jan 2024 //
FIERCE BIOTECH
Positive Results from Interim Analysis of `GEN-001` Plus avelumab PII Trial
19 May 2023 //
PR NEWSWIRE
CDMO List Labs Partners with Genome & Company
23 Sep 2021 //
CONTRACTPHARMA
Rome bags $77M to strike gold in the backwaters of the genome
14 Sep 2021 //
FIERCEBIOTECH
Genome of South Korea purchases CDMO List Labs for $27M
09 Sep 2021 //
FIERCEPHARMA
Genome & Company signs second clinical trial collaboration and supply agreement
09 Mar 2021 //
BIOSPACE
Genome & Company and Debiopharm Join Forces To Create New Highly Specific
24 Feb 2021 //
PRNASIA
Genome & Company receives FDA IND clearance for GEN-001
20 Apr 2020 //
PR NEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.